U.S. Entertainment Stock News

Kadant (KAI) opened Q1 2026 with revenue of US$281.5 million and basic EPS of US$2.16, while trailing twelve month EPS sat at US$8.78 on revenue of US$1.1 billion and net income of US$103.4 million. Over the last five reported quarters, revenue has ranged from US$239.2 million to US$286.2 million as basic EPS moved between US$2.04 and US$2.35. This gives investors a clear read on how the top and bottom lines have tracked together into this latest print. With trailing net margins at 9.4%...

In the first quarter of 2026, monday.com reported revenue of US$351.27 million and net income of US$28.03 million, while also lifting its full‑year revenue outlook. Ahead of this earnings release, the company unveiled its largest product overhaul yet, rebranding as an AI Work Platform with native, configurable AI agents and a new consumption-based pricing model aimed at monetizing AI usage across its customer base. We’ll now examine how monday.com’s launch of its AI Work Platform and...

REGENXBIO (RGNX) Q1 2026 earnings snapshot REGENXBIO (RGNX) has just posted Q1 2026 results with revenue of US$6.4 million and a basic EPS loss of US$1.72, against a trailing twelve month basic EPS loss of US$5.59 on revenue of US$87.8 million. Over recent quarters the company has reported revenue of US$89.0 million in Q1 2025, followed by US$21.4 million in Q4 2024. Basic EPS moved from a profit of US$0.12 in Q1 2025 to a loss of US$1.01 in Q4 2024. These figures are likely to draw investor...

Axon Enterprise reported past first-quarter 2026 results showing revenue of US$807.35 million versus US$603.63 million a year earlier, with net income rising from US$87.98 million to US$169.31 million and diluted earnings per share from continuing operations increasing from US$1.08 to US$2.05. The company also lifted its full-year 2026 revenue growth outlook to a range of 30% to 32%, underscoring how its expanding AI-driven product suite is reshaping Axon’s business mix and earnings...

Leggett & Platt, Incorporated has reported past first-quarter 2026 results showing sales of US$918.2 million, down from US$1,022.1 million a year earlier, with net income falling from US$30.6 million to US$20 million. The simultaneous decline in both revenue and profitability gives investors a fresh data point on how the company is managing current demand conditions and cost pressures. We’ll now examine how this quarter’s weaker sales and earnings reshape Leggett & Platt’s investment...

Recent share performance and business profile Novo Nordisk (NYSE:NVO) has drawn investor attention after a mixed stretch for the stock, with the share price down 12.6% year to date yet up 16.5% over the past month. The Denmark based pharmaceutical group reports US$327.8b in revenue and US$121.96b in net income, primarily from its Diabetes and Obesity Care segment, alongside a smaller Rare Disease business. See our latest analysis for Novo Nordisk. At a share price of US$45.80, Novo Nordisk...

Nebius Group (NasdaqGS:NBIS) has opened 2026 with Q1 revenue of US$399 million and Basic EPS of US$2.40, alongside net income of US$621.2 million, setting a clear marker after a volatile run of prior quarters. The company has seen revenue move from US$55.3 million in Q1 2025 and US$35.2 million in Q4 2024 to US$399 million in Q1 2026, with Basic EPS shifting from a loss of US$0.48 in Q1 2025 and a loss of US$0.58 in Q4 2024 to a profit of US$2.40. This puts the focus firmly on how sustainable...

Cooper Companies (NasdaqGS:COO) has appointed Paul Keel to its Board of Directors. Keel will also serve on the Board’s Audit Committee. The appointment brings experience from senior executive roles at major medical technology and industrial companies. For investors watching Cooper Companies at a share price of $60.38, this board change comes after a period of weak stock performance. The stock is down 15.7% over the past 30 days, 25.6% year to date, and 25.9% over the past year, with a 37.9%...

SS Innovations International (NasdaqCM:SSII) opened 2026 with Q1 revenue of about US$11.1 million and a basic EPS loss of US$0.02, while trailing 12 month figures show revenue of roughly US$48.5 million and a basic EPS loss of US$0.05. Over the past reported quarters, revenue has ranged from about US$5.1 million in Q1 2025 to US$14.5 million in Q4 2025, with basic EPS losses moving between roughly US$0.00 and US$0.03 per share. Investors are therefore likely to focus on how efficiently that...

YETI Holdings (YETI) opened 2026 with Q1 revenue of US$380.4 million and basic EPS of US$0.13, alongside trailing twelve month revenue of US$1.9 billion and EPS of US$2.01 that frame the latest quarter against a fuller earnings picture. Over recent quarters the company has seen revenue move from US$351.1 million and EPS of US$0.20 in Q1 2025 through US$583.7 million and EPS of US$0.76 in Q4 2025, setting a clear baseline for how this new print fits into the broader trend. With trailing net...

Escalating conflict in the Middle East, including closures around the Strait of Hormuz and issues at Iran’s Kharg Island terminal, has pushed oil prices higher and put Exxon Mobil (XOM) firmly back in focus for investors. See our latest analysis for Exxon Mobil. At a share price of US$152.78, Exxon Mobil has logged a 24.57% year to date share price return. Its 1 year total shareholder return of 45.19% and 5 year total shareholder return of 212.06% point to strong longer term compounding...

Biohaven Ltd. reported first-quarter 2026 results in the past, narrowing its net loss to US$130.53 million from US$221.68 million a year earlier, while loss per share from continuing operations declined to US$0.88 from US$2.17. On the same day, Biohaven filed an omnibus shelf registration covering a wide range of securities, potentially giving the company considerable flexibility in how it may access capital in the future. With these earnings and the broad shelf registration in mind, we’ll...

In May 2026, Valpak Intelligence announced that its New Mover and New Business audience segments became directly available in LiveRamp’s Data Marketplace, giving marketers, brands, and agencies streamlined access to its postal-anchored identity data across major DSPs, SSPs, CTV platforms, and CRM destinations without separate licensing agreements. This partnership brings Valpak’s decades-built household identity spine, spanning approximately 135 million households and hundreds of millions of...

vTv Therapeutics (VTVT) opened Q1 2026 with reported revenue of US$36.8 million and basic EPS of US$1.94, putting a spotlight on the shift in its income statement after a series of quarterly losses. Over the past year, the company has seen quarterly revenue move from effectively US$0 in early 2025 to US$36.8 million in Q1 2026, while basic EPS has swung from a loss of US$0.77 in Q1 2025 to a profit of US$1.94, indicating a sharp change in how much of each sales dollar is landing on the bottom...

Keros Therapeutics (KROS) has just posted Q1 2026 results, with revenue of US$0.4 million, a basic EPS loss of US$1.21 and a net loss of US$23.7 million, setting the tone for the quarter at a share price of US$10.99. The company has seen quarterly revenue move from US$211.2 million in Q1 2025 to US$0.4 million in Q1 2026, while basic EPS shifted from a profit of US$3.66 to a loss of US$1.21. This puts the spotlight on how changes in revenue expectations and potential margin developments could...

In early May 2026, Vertex Pharmaceuticals filed a new US$2.87 billion shelf registration for 6,400,000 common shares tied to its employee stock ownership plan after closing several earlier ESOP-related shelf programs, alongside reporting first-quarter 2026 revenue of US$2,986.9 million and net income of US$1,031.4 million. At the same time, Vertex expanded access for its one-time CRISPR/Cas9 therapy CASGEVY through a reimbursement agreement with Germany’s GKV-Spitzenverband and reaffirmed...

Robotaxi expansion puts DiDi Global (DIDI.Y) in focus DiDi Global (DIDI.Y) is drawing attention after moving faster on autonomous driving, securing a road test license in Beijing for its latest robotaxi and preparing pilot programs in the UAE. See our latest analysis for DiDi Global. Despite the robotaxi progress, recent momentum has been weak. The share price is US$3.58 with a year to date share price return down 35.61%, while the 3 year total shareholder return is 12.23%, hinting at a mixed...

Rapid Micro Biosystems (RPID) opened Q1 2026 with revenue of US$8.0 million and a basic EPS loss of US$0.31, while trailing twelve month revenue stood at US$34.4 million alongside a TTM basic EPS loss of US$1.11. Over recent quarters the company has seen revenue move between US$7.2 million and US$11.3 million, with quarterly basic EPS losses ranging from US$0.22 to US$0.31. This latest print keeps the focus squarely on how fast margins can tighten and losses can narrow from here. See our full...

In recent days, Texas Instruments reported better-than-expected first-quarter results, highlighting strong analog revenue growth powered by industrial demand and a sharp rise in AI data center-related sales, while sector-wide optimism around semiconductors has been reinforced by broader index gains and supportive earnings across many chipmakers. At the same time, management’s emphasis on analog and embedded processing strengths, expanding internal manufacturing capacity, and upcoming...

Versant Media Group (VSNT) opened Q1 2026 with revenue of US$1.7 billion and basic EPS of US$1.99, setting the tone for how investors will weigh the latest move in profitability. Over recent periods the company has seen quarterly revenue move from US$1.7 billion in Q1 2025 to US$1.6 billion in Q4 2025 and then to US$1.7 billion in Q1 2026, while net income excluding extra items shifted from US$334.5 million to US$181 million and then to US$286 million, giving a clear read on how earnings...

Earlier this week, STERIS plc reported its fourth-quarter and fiscal 2026 results, with full-year sales of US$5,935.9 million and net income of US$782.3 million, alongside new fiscal 2027 guidance calling for 7%–8% reported revenue growth and a fresh US$1.00 billion share repurchase authorization. Management paired record annual revenue and earnings per share with plans for substantial buybacks and elevated capital spending, signaling confidence in the durability of demand for its infection...

Kulicke and Soffa Industries recently reported fiscal second-quarter 2026 results, with sales rising to US$242.62 million and net income improving to US$35.15 million, a shift from a net loss a year earlier. Alongside the earnings rebound, the company outlined plans to increase capital spending to expand thermo-compression bonding capacity for advanced packaging used in AI and high-performance chips. We’ll now examine how this earnings improvement and stepped-up thermo-compression investment...

Wolverine World Wide (WWW) opened Q1 2026 with revenue of US$457.6 million and basic EPS of US$0.25, against a current share price of US$15.22. This sets a clear marker for how its latest quarter feeds into a steadily building earnings profile. The company has seen quarterly revenue move from US$412.3 million and EPS of US$0.13 in Q1 2025 to US$457.6 million and EPS of US$0.25 in Q1 2026. Trailing twelve month EPS stands at US$1.24 on revenue of roughly US$1.9 billion, giving investors a...

Why Ameriprise Financial (AMP) is back in focus Ameriprise Financial (AMP) is drawing fresh attention after Q1 2026 earnings highlighted revenue growth, firm operating margins, and a 12% year-over-year rise in assets under management to US$1.7b. See our latest analysis for Ameriprise Financial. The Q1 earnings beat and rising interest from investors like Gator Capital have helped the stock regain some traction, with a 2.9% 7 day share price return and a 3 year total shareholder return of...